Skip to main content
Atrás
ANSLF logo

Ansell Limited

Calidad de datos: 100%
Sobrecompra
ANSLF
OTC Healthcare Medical - Instruments & Supplies
$22.74
▲ $1.26 (5.54%)
Cap. Mercado: 3.28B
También listada como ANSLY OTC
Rango del Día
$22.74 $22.74
Rango de 52 Semanas
$18.00 $25.00
Volumen
2,000
Promedio 50D / 200D
$22.83 / $20.36
Cierre Anterior
$22.74

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E 32.3 0.3
P/B 1.7 3.0
ROE % 5.3 3.7
Net Margin % 5.1 3.8
Rev Growth 5Y % -0.5 10.0
D/E 0.4 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2029 $1.80
$1.75 – $1.87
 2.30B 5
FY2028 $1.66
$1.61 – $1.72
 2.23B 6
FY2027 $1.56
$1.52 – $1.62
 2.15B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-15 $0.65 $0.62 -3.4%
2025-08-24 $0.68 $0.22 -68.1%
2025-02-11 $0.55 $0.22 -60.5%
2024-08-20 $0.53 $0.29 -46.0%
2024-04-08 $0.41 $0.11 -73.1%
2023-06-30 $0.64 $0.43 -32.4%
2022-12-30 $0.55 $0.35 -36.9%
2022-06-30 $0.67 $0.42 -36.8%

Dividend History

Yield

0.02%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue declined -0.45% annually over 5 years
Earnings grew 32.81% over the past year
Debt/Equity of 0.41 — conservative balance sheet
Generating 170.00M in free cash flow
P/E of 32.30 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24.16%

Crecimiento

Revenue Growth (5Y)
-0.45%
Revenue (1Y)23.71%
Earnings (1Y)32.81%
FCF Growth (3Y)33.51%

Calidad

Return on Equity
5.27%
ROIC2.95%
Net Margin5.07%
Op. Margin5.45%

Seguridad

Debt / Equity
0.41
Current Ratio2.13
Interest Coverage2.32

Valoración

P/E Ratio
32.30
Forward P/EN/A
P/B Ratio1.67
EV/EBITDA35.28
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 23.71% Revenue Growth (3Y) 10.72%
Earnings Growth (1Y) 32.81% Earnings Growth (3Y) -17.23%
Revenue Growth (5Y) -0.45% Earnings Growth (5Y) -19.89%
Profitability
Revenue (TTM) 2.00B Net Income (TTM) 101.60M
ROE 5.27% ROA 3.06%
Gross Margin 41.18% Operating Margin 5.45%
Net Margin 5.07% Free Cash Flow (TTM) 170.00M
ROIC 2.95% FCF Growth (3Y) 33.51%
Safety
Debt / Equity 0.41 Current Ratio 2.13
Interest Coverage 2.32
Dividends
Dividend Yield 0.02% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 32.30 Forward P/E N/A
P/B Ratio 1.67 P/S Ratio 1.64
PEG Ratio 1.27 Forward PEG N/A
EV/EBITDA 35.28 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 5.18%
Market Cap 3.28B Enterprise Value 3.85B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.00B 1.62B 1.63B 1.85B 2.04B
Net Income 101.60M 76.50M 148.30M 158.70M 246.70M
EPS (Diluted) 0.71 0.59 1.15 1.18 1.91
Gross Profit 825.00M 624.80M 604.22M 625.19M 807.21M
Operating Income 109.10M 129.30M 210.50M 236.60M 343.82M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.32B 3.24B 2.52B 2.51B 2.74B
Total Liabilities 1.34B 1.33B 913.07M 949.48M 1.17B
Shareholders' Equity 1.96B 1.89B 1.60B 1.54B 1.55B
Total Debt 805.60M 857.20M 493.15M 485.74M 515.53M
Cash & Equivalents 238.30M 912.30M 159.03M 206.18M 240.21M
Current Assets 1.11B 1.62B 909.88M 984.38M 1.17B
Current Liabilities 522.00M 423.40M 413.63M 360.26M 549.93M

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#608 of 1052
41

Actividad Reciente

Entró Cash Flow Compounder
Mar 24, 2026